相关实验视频

Updated: Apr 16, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

一个磁力驱动的可生物降解微球,具有大量生产能力,用于分单元疫苗输送和增强免疫疗法

Qi Zhang¹, Yun Qu¹, Han Zhao¹

¹Department of Biomedical Engineering, City University of Hong Kong, 999077 Hong Kong, SAR, China.

ACS applied materials & interfaces

|September 12, 2024

概括

这项研究在凝甲基 (GelMA) 微球 (OMGMs) 中引入了卵@磁性纳米粒子 (OVA@MNPs),以改善亚单元疫苗的输送. OMGMs增强了对淋巴结的抗原传递,促进了免疫反应和抗瘤作用.

科学领域:

免疫治疗是一种免疫疗法.
疫苗输送系统的系统.
纳米技术纳米技术

背景情况:

亚单元疫苗对病毒感染和癌症免疫疗法有希望.
临床使用受到较差的抗原递送,快速清除和较低的细胞吸收限制.
需要新的输送系统来提高亚单元疫苗的疗效.

研究的目的:

开发一种新型的子单位疫苗输送系统,使用在可生物降解的凝甲基 (GelMA) 微球 (OMGM) 中封装的卵@磁性纳米粒子 (OVA@MNPs).
为了提高抗原递送效率,淋巴系统向和持续释放以加强免疫疗法.
在小鼠模型中评估OMGMs在体内疗效,以改善免疫反应和抗瘤作用.

主要方法:

使用微流体液滴生成制造OVA@MNP装载的GelMA微球 (OMGMs).
磁场引导的OMGMs向淋巴系统的输送.
评估在淋巴结和抗原呈现细胞中的抗原积累.
在小鼠模型中评估细胞和幽默免疫力和抗瘤作用.

主要成果:

OMGMs证明了高效的磁性向和在淋巴结中的抗原的积累.
从可生物降解的GelMA微球中观察到抗原的持续释放.
增强的细胞和幽默免疫反应是由OMGMs诱导的.
通过使用OMGMs进行单次增强免疫接种,获得了显著的抗瘤效应.

结论:

转基因基因组代表了一种实用和有效的亚单元疫苗接种方法.
这种系统克服了子单位疫苗抗原传递效率的局限性.
转基因基因组对抗癌症和病毒感染的先进免疫治疗策略有前途.

关键词:

生物降解生物降解免疫疗法免疫疗法这些微球是微球.纳米颗粒是一种纳米粒子.部分单位的疫苗输送.

更多相关视频

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

相关概念视频

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.